Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$151K Sell
1,800
-76,600
-98% -$6.31M 0.01% 503
2025
Q2
$6.21M Buy
78,400
+5,800
+8% +$461K 0.23% 107
2025
Q1
$6.52M Buy
72,600
+25,900
+55% +$2.42M 0.27% 101
2024
Q4
$4.65M Sell
46,700
-31,600
-40% -$3.26M 0.17% 166
2024
Q3
$8.89M Buy
78,300
+71,200
+1,003% +$8.46M 0.3% 88
2024
Q2
$879K Buy
7,100
+5,100
+255% +$657K 0.03% 539
2024
Q1
$264K Buy
+2,000
New +$247K 0.01% 902

Other funds holding MRK

Point72 (DIFC)'s MRK Position: Q3 2025 in Review

Point72 (DIFC) increased its Merck (MRK) stake by 1,638% in Q3 2025, buying an estimated $540K and bringing the position to 6,951 shares worth $583K. The position accounts for 0.04% of the portfolio, ranked #253.

Point72 (DIFC) first reported a position in MRK in Q1 2024 and has held it in 6 quarters since. The position peaked at $16.4M in Q1 2024. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Point72 (DIFC) held 6,951 shares of Merck worth $583K as of Q3 2025.
  • Point72 (DIFC) bought 6,551 Merck shares in Q3 2025, an estimated $540K.
  • Merck made up 0.04% of Point72 (DIFC)'s portfolio in Q3 2025, its #253 holding.
  • Point72 (DIFC) first reported a position in Merck in Q1 2024 and has held it in 6 quarters since.
  • Point72 (DIFC)'s Merck position peaked at $16.4M in Q1 2024.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.